These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18669715)

  • 41. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
    Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluating the applicability of MoM in second trimester maternal serum to screening for Down's syndrome in Jiangsu province].
    Xu BY; Hu Y; Zhang CY; Zhang JW; Liu QL; Yue H; Ru T; Xu ZF; Zhu RF; Zhang Y; Zhong X; Wu QM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):32-5. PubMed ID: 18247300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316.
    Watts DH; Balasubramanian R; Maupin RT; Delke I; Dorenbaum A; Fiore S; Newell ML; Delfraissy JF; Gelber RD; Mofenson LM; Culnane M; Cunningham CK;
    Am J Obstet Gynecol; 2004 Feb; 190(2):506-16. PubMed ID: 14981398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contingent screening for Down syndrome--results from the FaSTER trial.
    Cuckle HS; Malone FD; Wright D; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Ferreira JC; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; D'Alton ME
    Prenat Diagn; 2008 Feb; 28(2):89-94. PubMed ID: 18236423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome.
    Ganapathy R; Lamont RF; Bassett P
    Prenat Diagn; 2007 Nov; 27(11):995-9. PubMed ID: 17621365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction.
    Odibo AO; Sehdev HM; Stamilio DM; Macones GA
    Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of bias in MoM values on patient risk and screening performance for Down syndrome.
    Nix B; Wright D; Baker A
    Prenat Diagn; 2007 Sep; 27(9):840-5. PubMed ID: 17600858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Midtrimester triple-test levels in women with chronic hypertension and altered renal function.
    Shenhav S; Gemer O; Sherman DJ; Peled R; Segal S
    Prenat Diagn; 2003 Feb; 23(2):166-7. PubMed ID: 12575027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of fetal gender on second-trimester maternal serum inhibin-A concentration.
    Lam YH; Tang MH
    Prenat Diagn; 2001 Aug; 21(8):662-4. PubMed ID: 11536266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
    Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
    Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
    Dugoff L; Cuckle HS; Hobbins JC; Malone FD; Belfort MA; Nyberg DA; Comstock CH; Saade GR; Eddleman KA; Dar P; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Am J Obstet Gynecol; 2008 Sep; 199(3):290.e1-6. PubMed ID: 18771987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum ferritin levels in normal and HIV-1 infected pregnant women.
    Phuapradit W; Taeepanichskul S; Jetsawangsri T; Chaturachinda K; Khupulsup K; Kunakorn M
    Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):24-6. PubMed ID: 8775245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.
    Livingston EG; Cohn SE; Yang Y; Watts HD; Bardeguez AD; Jones TB; Smith LM; Umbleja T; McComsey GA
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):391-7. PubMed ID: 17666616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum leptin in first-trimester Down syndrome pregnancies.
    Hedley P; Christiansen M
    Prenat Diagn; 2008 Jun; 28(6):475-7. PubMed ID: 18437707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.
    Melvin AJ; Kang M; Hitti J; Livingston E; Cohn SE; Stocker V; Ross AC; Watts H; McComsey GA
    Antivir Ther; 2008; 13(3):349-55. PubMed ID: 18572747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
    Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
    Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using Down syndrome serum screening results to predict low birthweight.
    Huang T; Alberman E; Watt HC; Wald NJ
    Prenat Diagn; 2003 May; 23(5):420-6. PubMed ID: 12749041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of HIV infection and antiretroviral therapy on the predicted risk of Down syndrome.
    Charlton TG; Franklin JM; Douglas M; Short CE; Mills I; Smith R; Clarke A; Smith J; Tookey PA; Cortina-Borja M; Taylor GP
    Prenat Diagn; 2014 Feb; 34(2):121-7. PubMed ID: 24284802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.